Becton Dickinson Banks $540M With Surgical Unit Sale, 360 Employees To Join Steris
Portfolio Pulse from Nabaparna Bhattacharya
Becton Dickinson (BDX) has agreed to sell its Surgical Instrumentation platform to Steris (STE) for $540 million. The deal will help BDX focus on its capital allocation priorities and support its BD 2025 expansion strategy. Approximately 360 BDX employees will transfer to Steris upon completion of the transaction.
June 20, 2023 | 4:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Becton Dickinson sells its Surgical Instrumentation platform to Steris for $540 million, supporting its BD 2025 expansion strategy.
The sale of the Surgical Instrumentation platform will provide BDX with cash proceeds to focus on its capital allocation priorities and support its BD 2025 expansion strategy. While the deal may streamline operations, it is not clear how it will directly impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Steris acquires Becton Dickinson's Surgical Instrumentation platform for $540 million, complementing its Healthcare segment.
The acquisition of BDX's Surgical Instrumentation platform will complement Steris's Healthcare segment and potentially strengthen its market position. This could have a positive impact on STE's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100